batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Some backing for Arcus's HIF2α bet 6 October 2025 Pfizer fuels Cartography push 3 October 2025 Different problem, same result for Bolt 2 October 2025 Debiopharm ups its bispecific conjugate push 1 October 2025 Sutro trims again 30 September 2025 Second in line for ESR1-mutant patients 26 September 2025 Promised pivotal head-to-head studies materialise 26 September 2025 Dual-payload conjugates see CDK7 debut 25 September 2025 Load More